ArticleInternational journal of public health2025
PM2.5-Related Burden of Tracheal, Bronchial, and Lung Cancer in China, the United States, Japan, and South Korea (1990-2021).
Article in International journal of public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To quantify the tracheal, bronchial, and lung cancer burden attributable to particulate matter pollution in selected countries, and thereby provide evidence for context - specific public health interventions. Methods: Based on Global Burden of Disease (GBD) 2021 data,we appliedJoinPoint to analyze the temporal trends from 1990-2021 in the burden of PM2.5 - attributable tracheal, bronchial, and lung (TBL) cancer in China, the US, Japan, and South Korea. And we explored the age, period, cohort effects and predicted future trends using the age-period-cohort mode and Bayesian analysis. Results: Globally, the age-standardized mortality rate (ASMR) for TBL cancers due to PM2.5 exposure showed a declining trend with an average annual percentage change (AAPC) of-1.2811 from1990 to 2021, projections suggest continued decreases in ASMR in selected countries over the next 29 years, but a global increase is expected. Conclusion: Studies have demonstrated a global decline in the mortality burden attributed to bronchogenic carcinoma linked to PM2.5. Nevertheless, future projections indicate that the global burden of air pollution-related TBL cancer will rise, effective public health strategies are urgent to develop.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.